Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OPTIMIZERx Corp OPRX

Healthcare Medical Devices
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables... see more

Recent & Breaking News (NDAQ:OPRX)

OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands

GlobeNewswire September 20, 2022

OptimizeRx to Participate in Upcoming September Conferences

GlobeNewswire September 7, 2022

OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program

GlobeNewswire August 23, 2022

UPDATE - OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense

GlobeNewswire August 9, 2022

OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense

GlobeNewswire August 9, 2022

OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership

GlobeNewswire July 26, 2022

OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET

GlobeNewswire July 21, 2022

OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership

GlobeNewswire June 23, 2022

OptimizeRx Completes Platform Integration of TelaRep(TM) One-Click Prescriber Connectivity Solution

GlobeNewswire June 7, 2022

OptimizeRx to Participate in Upcoming June Conferences

GlobeNewswire May 24, 2022

OptimizeRx's Mike Rousselle Named One of 2022 PM360 ELITE 100

GlobeNewswire May 17, 2022

OptimizeRx Authorizes $20 Million Share Repurchase Program

GlobeNewswire May 17, 2022

OptimizeRx to Participate in Upcoming May Conferences

GlobeNewswire May 10, 2022

OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition

GlobeNewswire May 4, 2022

OptimizeRx Releases First Environmental, Social and Governance (ESG) Report

GlobeNewswire April 29, 2022

OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4:30 p.m. ET

GlobeNewswire April 21, 2022

UPDATE - Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients

GlobeNewswire April 20, 2022

1 in 3 Surveyed Physicians Say They Would Make a Different Treatment Choice If Medication Access Was Not a Factor

GlobeNewswire April 19, 2022

Financial Times Ranks OptimizeRx Amongst Americas' Fastest-Growing Companies for the Third Consecutive Year

GlobeNewswire April 5, 2022

Augmedix Names William Febbo as New Member to its Board of Directors

GlobeNewswire March 29, 2022